The Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal (UdeM) recently launched the 2013 edition of its Summer School in Systems Biology. This year, twenty-seven students pursuing graduate studies at IRIC or at other research centers in Montreal will participate in the different courses of the Summer School to acquire [...]

The Cole Foundation held its annual Research Celebration Day at the Université de Montréal on May 10th. On this occasion, IRIC’s graduate students and postdoctoral fellows were awarded six of the ten 2013-2015 Cole Foundation Fellowships and also won three prizes for best poster presentations of the day.  The Cole Foundation was established in 1980 [...]

The Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal is proud to announce that Danielle de Verteuil, Ph.D. student in molecular biology, systems biology option, under the supervision of Dr Claude Perreault, has won the first prize at the final of Acfas’  Votre soutenance en 180 secondes national competition. This event, [...]

Genome Canada announced the successful projects resulting from the 2012 Bioinformatics and Computational Biology Competition. The Competition supports the next generation of tools that are required to deal with the large amounts of data produced by modern genomics technologies and to provide the research community broad access to these tools. Drs Mike Tyers of IRIC [...]

IRICoR, the Institute for Research in Immunology and Cancer – commercialization of Research (IRICoR) of Université de Montréal received on Monday a $4 million contribution from Merck Canada for the establishment of corridor projects in collaboration with two other Centres of Excellence for Commercialization and Research (CECR), based in Ontario and British Columbia.  This investment [...]

Yesterday, Genome Quebec announced two 4-year multi-million dollar grants awarded to Drs Claude Perreault and Guy Sauvageau, both principal investigators at the Institute for Research in Immunology and Cancer (IRIC) and practicing clinicians at Hôpital Maisonneuve-Rosemont (HMR), a reference center in hematology-oncology.  The two projects developed by IRIC scientists with the support of UdeM’s drug development and [...]

Patients with the misfortune to be diagnosed with one of the deadliest forms of leukemia may soon benefit from a unique collaboration aiming to give them new hope against their blood cancer. Pharmascience Inc. and Université de Montréal (UdeM) today announced the signing of an agreement which formalizes and brings to the next level of activity [...]

On March 15th, the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal unveiled the winners of the first edition of its IRIC Members Ph.D. Awards program. This programs aims to award $20,000 scholarships to doctoral students who stand out for their motivation, their excellent academic records and great scientific productivity. “By [...]

A team of scientists from IRIC lead by Dr. Gregory Emery, and their colleagues from the Johns Hopkins University School of Medicine in Baltimore, recently identified a new mechanism controlling a type of cell movement implicated in cancer, called collective cell migration. Their recent study was just published in the March issue of the prestigious scientific journal Nature [...]

The Institute for Research in Immunology and Cancer (IRIC) of Université de Montréal and IRICoR, its Centre of Excellence for Commercialization and Research (CECR), welcome the announcement made Friday, February 15 of the creation of the Partnership for Personalized Medicine in Cancer (Partenariat pour la médecine personnalisée en cancer, PMPC). The Minister of Finance of Québec, [...]